NanOlogy Announces First Patient Enrolled In A Phase II Clinical…

DALLAS & FT. WORTH, Texas-- -- NanOlogy LLC , a clinical-stage pharmaceutical development company, today announced enrollment of the first patient in a Phase 2 clinical trial of intraperitoneally administered NanoPac sterile suspension in patients with...
Continue reading » · Written on: 10-09-17 · No Comments »